37^th Conference on Preventive Oncology and Diagnostic Cancer September 19-20, 2024 Paris, France

The 37^th Conference on Preventive Oncology and Diagnostic Cancer, Preventive Oncology 2024, offers a unique opportunity to engage with the latest advancements and best practices in cancer prevention and early detection. By attending this conference, you will:

Stay Informed: Gain insights into the latest research, trends, and innovations in preventive oncology and diagnostic cancer from leading experts and researchers.

Expand Your Knowledge: Learn about new strategies, technologies, and approaches to cancer prevention and early detection that you can apply in your practice or research.

Network: Connect with professionals, peers, and industry leaders from around the world, fostering collaborations and expanding your professional network.

Showcase Your Work: Present your research through poster presentations and gain valuable feedback from peers and experts in the field.

Access to Experts: Engage with renowned speakers and experts through keynote lectures, panel discussions, and interactive sessions.

Professional Development: Enhance your skills and knowledge in oncology, radiology, pathology, and related fields through workshops and educational sessions.

Explore Paris: Experience the vibrant city of Paris, known for its rich history, culture, and culinary delights, while attending the conference.

Be Part of a Transformative Event: Contribute to the advancement of cancer prevention and early detection by participating in discussions and sharing your insights and experiences.

Takeaway Resources: Access conference materials, presentations, and resources to further enhance your learning and professional development.

Don't miss this opportunity to be part of a dynamic and informative conference that will shape the future of cancer prevention and early detection. Register now to secure your spot at Preventive Oncology 2024.

The 37^th Conference on Preventive Oncology and Diagnostic Cancer, Preventive Oncology 2024, welcomes a wide range of professionals, researchers, educators, and students with an interest in cancer prevention and early detection. This includes, but is not limited to:

• Oncologists
• Radiologists
• Pathologists
• Genetic Counselors
• Public Health Professionals
• Epidemiologists
• Researchers
• Policy Makers
• Students and Trainees in the field of oncology, public health, and related disciplines

Whether you are a seasoned expert or a student looking to learn from leaders in the field, Preventive Oncology 2024 offers a valuable opportunity to engage with the latest research, trends, and innovations in cancer prevention and early detection. Join us in Paris for an enriching and informative conference experience.

1. Cancer Prevention Strategies: This session will focus on various strategies and interventions aimed at reducing the risk of developing cancer, including lifestyle modifications, nutritional interventions, and physical activity recommendations.

   • Lifestyle Modifications and Cancer Risk Reduction
   • Nutritional Interventions in Cancer Prevention
   • Physical Activity and Cancer Prevention

2. Vaccination and Cancer Prevention: This session will explore the role of vaccinations, such as HPV and hepatitis B vaccines, in preventing specific types of cancers. It will discuss the effectiveness of vaccines and their impact on cancer prevention.

   • HPV Vaccination and Cervical Cancer Prevention
   • Hepatitis B Vaccination and Liver Cancer Prevention
   • Emerging Vaccines in Cancer Prevention

3. Screening and Early Detection: This session will cover the importance of regular screenings, such as mammograms, colonoscopies, and Pap smears, in detecting cancer at an early and more treatable stage. It will discuss screening guidelines and best practices.

   • Screening Guidelines and Best Practices
   • Advances in Mammography and Breast Cancer Screening
   • Colonoscopy and Colorectal Cancer Screening
   • Prostate Cancer Screening: PSA Tests and Beyond

4. Genetic Counseling and Testing: This session will focus on the role of genetic counseling and testing in identifying individuals at higher risk for cancer due to inherited genetic mutations. It will discuss the benefits and implications of genetic testing for cancer prevention.

   • Genetic Risk Assessment and Cancer Prevention
   • BRCA Mutations and Preventive Measures for Breast and Ovarian Cancer
   • Genetic Counseling: Ethical and Practical Considerations

5. Public Health and Policy in Cancer Prevention: This session will explore public health initiatives and policies aimed at cancer prevention. It will discuss community-based programs, health campaigns, and policy measures to reduce the burden of cancer.

   • Public Health Campaigns and Cancer Awareness
   • Health Policy and Cancer Prevention Programs
   • Community-based Cancer Prevention Initiatives

6. Chemoprevention: This session will discuss the use of drugs and agents to reduce the risk of cancer development. It will cover clinical trials, emerging therapies, and the benefits and risks of chemoprevention.

   • Drugs and Agents in Cancer Prevention
   • Clinical Trials in Chemoprevention
   • Benefits and Risks of Chemoprevention

7. Advances in Diagnostic Imaging: This session will highlight recent advancements in diagnostic imaging technologies, such as mammography, MRI, and CT scans, for detecting cancer. It will discuss the role of imaging in early diagnosis and treatment planning.

   • Innovations in Mammography, MRI, and CT Scans
   • PET Scans in Cancer Detection and Monitoring
   • Ultrasound Techniques in Cancer Diagnosis

8. Biopsy and Histopathology: This session will focus on biopsy techniques and histopathological examination for diagnosing cancer. It will discuss the role of pathologists and surgeons in obtaining and analyzing tissue samples.

   • Techniques in Biopsy and Tissue Sampling
   • Pathological Examination and Cancer Diagnosis
   • Role of Immunohistochemistry in Cancer Diagnosis

9. Molecular and Genetic Diagnostics: This session will cover the use of molecular and genetic tests for diagnosing cancer. It will discuss genomic profiling, liquid biopsies, and biomarkers used in cancer diagnosis.

   • Genomic Profiling and Cancer Diagnosis
   • Liquid Biopsies: Techniques and Applications
   • Biomarkers in Cancer Detection and Prognosis

10. Laboratory Diagnostics: This session will discuss the role of laboratory tests, such as blood tests and cytology, in cancer diagnosis. It will cover the latest advancements in laboratory diagnostics for cancer detection.

    • Blood Tests and Cancer Markers
    • Advances in Cytology and Cancer Detection
    • Role of Laboratory Medicine in Cancer Diagnosis

11. Screening Technologies: This session will explore emerging technologies, such as digital tools and AI, used in cancer screening. It will discuss non-invasive and minimally invasive screening methods and their applications.

    • Emerging Technologies in Cancer Screening
    • Digital Tools and Artificial Intelligence in Cancer Diagnosis
    • Non-invasive and Minimally Invasive Screening Methods

12. Multidisciplinary Approaches in Cancer Diagnosis: This session will highlight the importance of multidisciplinary collaboration in cancer diagnosis. It will discuss case studies and collaborative approaches among radiologists, pathologists, and oncologists.

    • Integrating Diagnostic Techniques for Comprehensive Care
    • Collaboration Among Radiologists, Pathologists, and Oncologists
    • Case Studies in Multidisciplinary Cancer Diagnosis

13. Patient Care and Diagnostic Pathways:This session will focus on improving patient care and outcomes through effective diagnostic pathways. It will discuss ethical considerations, patient perspectives, and best practices in cancer diagnosis and care.

    • Improving Diagnostic Accuracy and Patient Outcomes
    • Navigating the Diagnostic Pathway: Patient Perspectives
    • Ethical Considerations in Cancer Diagnosis

These sessions aim to provide a comprehensive overview of preventive oncology and diagnostic cancer, covering various aspects of cancer prevention, early detection, and diagnosis.

1. Conference Attendance: Participants will have access to all conference sessions, including keynote lectures, panel discussions, and workshops, providing a comprehensive overview of the latest advancements in cancer prevention and early detection.

2. Networking Opportunities: Engage with professionals, researchers, and experts from around the world, fostering collaborations and expanding your professional network.

3. Poster Presentation: Showcase your research through poster presentations, gaining valuable feedback and insights from peers and experts in the field.

4. Exhibition Area: Explore the latest products, services, and technologies in oncology from leading companies and organizations, offering a firsthand look at the latest innovations in the field.

5. Continuing Education Credits: Earn continuing education credits by attending conference sessions and workshops, enhancing your professional development and credentials.

6. Access to Resources: Gain access to conference materials, presentations, and resources, allowing you to further enhance your learning and stay informed on the latest trends and research in cancer prevention and early detection.

7. Professional Development: Enhance your skills and knowledge in oncology, radiology, pathology, and related fields through educational sessions and workshops led by experts in the field.

8. Publication Opportunities: Selected papers and abstracts presented at the conference may have the opportunity to be published in reputable journals, increasing visibility and recognition for your research.

9. Cultural Experience: Experience the vibrant city of Paris, known for its rich history, culture, and culinary delights, adding a unique cultural experience to your conference attendance.

10. Impactful Contributions: By participating in Preventive Oncology 2024, you will contribute to the advancement of cancer prevention and early detection, making a meaningful impact in the fight against cancer.

Join us at Preventive Oncology 2024 to take advantage of these participant options and benefits, and be part of this transformative event.

Top 20 Global Associates:

1. American Association for Cancer Research (AACR) - aacr.org
2. American Society of Clinical Oncology (ASCO) - asco.org
3. European Society for Medical Oncology (ESMO) - esmo.org
4. International Agency for Research on Cancer (IARC) - iarc.fr
5. World Health Organization (WHO) - who.int
6. National Cancer Institute (NCI) - cancer.gov
7. International Union Against Cancer (UICC) - uicc.org
8. Cancer Research UK - cancerresearchuk.org
9. American Cancer Society (ACS) - cancer.org
10. European Association for Cancer Research (EACR) - eacr.org
11. Canadian Cancer Society - cancer.ca
12. Asian Pacific Organization for Cancer Prevention (APOCP) - apocp.org
13. Australasian Society for Breast Disease (ASBD) - asbd.org.au
14. Union for International Cancer Control (UICC) - uicc.org
15. Oncology Nursing Society (ONS) - ons.org
16. Japanese Cancer Association (JCA) - jca.gr.jp
17. Society of Surgical Oncology (SSO) - surgonc.org
18. National Comprehensive Cancer Network (NCCN) - nccn.org
19. Society for Immunotherapy of Cancer (SITC) - sitcancer.org
20. European Cancer Organisation (ECCO) - europeancancer.org

Top 20 Societies:

1. American Society of Preventive Oncology (ASPO) - aspo.org
2. European Society for Preventive Oncology (ESPO) - espo.eu.com
3. International Society for Preventive Oncology (ISPO) - cancerprev.org
4. Society for Cancer Prevention (SCP) - socprev.org
5. Prevent Cancer Foundation - preventcancer.org
6. British Society for Immunology - immunology.org
7. Society for Integrative Oncology (SIO) - integrativeonc.org
8. Association of Community Cancer Centers (ACCC) - accc-cancer.org
9. European Society of Breast Cancer Specialists (EUSOMA) - eusoma.org
10. National Society of Genetic Counselors (NSGC) - nsgc.org
11. International Psycho-Oncology Society (IPOS) - ipos-society.org
12. Oncology Nursing Society (ONS) - ons.org
13. International Association for the Study of Lung Cancer (IASLC) - iaslc.org
14. American Radium Society (ARS) - americanradiumsociety.org
15. European Society of Gynecological Oncology (ESGO) - esgo.org
16. European Oncology Nursing Society (EONS) - cancernurse.eu
17. Society for Translational Oncology (STO) - sto-online.org
18. Association of European Cancer Leagues (ECL) - europeancancerleagues.org
19. World Federation of Surgical Oncology Societies (WFSOS) - wfsos.org
20. International Society for Pediatric Oncology (SIOP) - siop-online.org

Top 20 Universities:

1. Harvard University - harvard.edu
2. University of Oxford - ox.ac.uk
3. Stanford University - stanford.edu
4. University of Cambridge - cam.ac.uk
5. Johns Hopkins University - jhu.edu
6. Massachusetts Institute of Technology (MIT) - mit.edu
7. University of California, San Francisco (UCSF) - ucsf.edu
8. University of California, Los Angeles (UCLA) - ucla.edu
9. University of Toronto - utoronto.ca
10. Karolinska Institute - ki.se
11. Imperial College London - imperial.ac.uk
12. University of Sydney - sydney.edu.au
13. University of Melbourne - unimelb.edu.au
14. National University of Singapore (NUS) - nus.edu.sg
15. University of Tokyo - u-tokyo.ac.jp
16. University of Pennsylvania (Penn) - upenn.edu
17. University of Chicago - uchicago.edu
18. Yale University - yale.edu
19. University of Michigan - umich.edu
20. University of Washington - washington.edu

The size of the cancer diagnostics market is projected to be USD 106.24 billion in 2024 and USD 156.97 billion by 2029, with a compound annual growth rate (CAGR) of 8.12% from 2024 to 2029.

The COVID-19 pandemic has resulted in a significant decrease in the number of newly diagnosed cancer cases. The first wave of the pandemic saw a 31% drop in new colorectal cancer referrals compared to the average of the preceding two years, according to data from PubMed released in May 2021. Due to worries about virus transmission, endoscopic diagnosis was discontinued for cancer patients, making them more vulnerable to care disruptions. Therefore, it was discovered that the market under study was significantly impacted by COVID-19. Nonetheless, the market under study has grown to its pre-pandemic level in terms of cancer diagnostic procedures carried out, and it is anticipated to have robust growth during the forecast with the relaxation of all COVID-19 restrictions.

Growth in the market is primarily being driven by the increasing global prevalence of cancer, the ease with which cancer is now diagnosed, and the developments in cancer diagnostics, particularly in the areas of biomarkers and point-of-care diagnosis.

The two main drivers driving the global market for cancer diagnostics growth are the rise in the number of cancer patients and the aging population. Data released in November 2022 by the Canadian Cancer Society indicates that approximately 233,900 Canadians were coping with cancer in 2022. According to Globocan's forecast, by 2040, there would be over 30 million cancer patients worldwide. Thus, it is anticipated that the increasing cancer incidence rate globally will fuel market expansion in the next years.